半夏泻心汤加减联合雷贝拉唑与莫沙必利治疗慢性胃炎的有效性

Efficacy of Banxia Xiexin Decoction Combined with Rabeprazole and Mosapride in the Treatment of Chronic Gastritis

目的:探讨半夏泻心汤加减联合雷贝拉唑与莫沙必利治疗慢性胃炎的有效性及对患者不良反应发生的影响。方法:选取某院在2019年6月~2020年1月确诊并治疗的78例慢性胃炎患者,依据不同治疗方法分为对照组和研究组,对照组应用雷贝拉唑与莫沙必利,研究组联合应用半夏泻心汤加减,观察比较两组的有效性及不良反应。结果:研究组有效性比对照组高(P<0.05),两组的不良反应比率无显著差异(P>0.05)。结论:给予慢性胃炎患者在雷贝拉唑与莫沙必利基础上联合使用半夏泻心汤加减,可显著提高治疗有效性,且不会增加患者的不良反应。

Objective:To investigate the effectiveness of Banxia Xiexin decoction combined with rabeprazole and mosapride in the treatment of chronic gastritis and its influence on the occurrence of adverse reactions in patients.Methods:78 patients with chronic gastritis diagnosed and treated in a hospital from June 2019 to January 2020 were selected and distinguished according to different treatment methods.Rabeprazole and mosapride were used in the control group,and Banxia Xiexin decoction based on the control group was used in the study group.The effectiveness and adverse reactions of the two groups was observed and compared.Results:The effectiveness of the study group was higher than the control group(P<0.05).There was no significant difference in the rate of adverse reactions between the two groups(P>0.05).Conclusion:The combination of rabeprazole and moxapride with Banxia Xiexin decoction for chronic gastritis patients can significantly improve the effectiveness of treatment without increasing the adverse reactions of patients.